Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections



Status:Completed
Conditions:Infectious Disease, Pulmonary
Therapuetic Areas:Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:5/4/2018
Start Date:May 29, 2015
End Date:March 30, 2018

Use our guide to learn which trials are right for you!

In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will
implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce
low-value antibiotics for URIs. Using a quasi-experiment (pre-post) design, antibiotic
prescriptions for URI at LAC+USC Urgent Care Center (intervention site) vs. Olive View-UCLA
Urgent Care Center (control site) will used to test the effects of behavioral "nudge" on
antibiotic prescribing.

National prescription rates for low-value antibiotics for uncomplicated upper respiratory
infections (URIs) remain unacceptably high, including at LAC+USC Medical Center—one of the
largest safety net medical centers in the U.S. Using a quasi-experiment (pre-post) design,
antibiotic prescriptions for URI at LAC+USC Urgent Care Center (intervention site) vs. Olive
View-UCLA Urgent Care Center (control site) will be compared. A three-part intervention at
LAC+USC consists of (1) the urgent care medical director emailing Choosing Wisely® guidelines
and presented journal club to all 16 urgent care clinicians, and then (2) leveraging EHR
performance data to provide individual clinicians with case-specific audit-feedback (both via
emails and in-person while precepting nurse practitioners) on low-value antibiotic
prescribing, and (3) using a behavioral "nudge", urgent care clinicians will sign a large
poster committing to avoid prescribing low-value antibiotics for uncomplicated URIs, which
will be displayed in the clinic. In contrast, the control site (Urgent Care Center at Olive
View-Medical Center) will receive Centers for Disease Control prescription pads for
non-antibiotic treatments (e.g., decongestants) that offer patients alternatives to
antibiotics, in a broader health system effort to reduce antibiotic prescribing. Patient with
URIs (e.g., acute bronchitis, bronchitis NOS, excluding guideline-based red flags such as
COPD, HIV) will be identified using electronic health record clinical billable data and
low-value antibiotic prescriptions rates per visit will be monitored at both sites.
Differences in prescriptions rates will be determined using an interrupted time-series
analysis comparing utilization between sites using a repeated measures logistic regression
model.

Inclusion Criteria:

- all patient receiving treatment for Upper Respiratory Infections (defined by ICD codes
EHR billable codes) at both LAC+USC Medical Center Urgent Care or Olive View-UCLA
Medical Center

Exclusion Criteria:

- Patients not receiving treatment for Upper Respiratory Infections at both LAC+USC
Medical Center Urgent Care or Olive View-UCLA Medical Center
We found this trial at
1
site
Los Angeles, California 90033
Phone: 323-409-6535
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials